"The healthcare field is living in an era of unpredictable changes and developments. New scientific discoveries, with the help of advancing technology, enable us to better understand diseases and create new medical solutions. Our vision; is to transform innovative science into value for patients as a pioneer of change in health."

  • Getron PBD
  • Getron OMP
  • Healthcare

"At Astellas, our hope is to change tomorrow.

As a young and forward-thinking company, Astellas is committed to improving the health of people around the world by offering innovative and reliable products.

Established in 2005 with the merger of Yamanouchi and Fujisawa companies, Astellas has continued to grow in the world pharmaceutical industry by combining important Research and Development and promotional activities, and maintains its determination to develop first-in-class and best-in-class products in basic treatment areas.

Astellas offers pharmaceutical products in the fields of Organ Transplantation, Urology, Anti-infective and Oncology in Turkey.

Astellas Pharmaceuticals started to operate in Turkey in 2008.

It aims to offer its current and innovative products in all treatment areas in Turkey and continues to work intensively for this.

CHANGING TOMORROW «CHANGE THE FUTURE» is our motto. Our motto represents our determination to continue our work as long as there are people suffering from the disease and to provide a brighter future for all patients battling the disease.

CHANGE THE FUTURE describes in just two words our core feature and the primary benefit we provide to all our shareholders.

With its significant ongoing investments in R&D, Astellas aims to be a research-oriented pharmaceutical company by providing effective treatments to patients worldwide and continuing to establish reliable relationships between physicians and all stakeholders.